Srs Capital Advisors, Inc. I Bio, Inc. Transaction History
Srs Capital Advisors, Inc.
- $1.07 Billion
- Q3 2024
About iBio, Inc.
- Ticker IBIO
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 9,006,580
- Market Cap $23.8M
- Description
- iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...